SCHEMBL2575351

SCHEMBL2575351

Nc1ncc(Cc2ccc3ncccc3c2)nc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.51
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
ATM Q13315 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
TSHR P16473 1/20 0.49
CASP1 P29466 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PDE10A Q9Y233 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
POLB P06746 1/20 0.44
HDAC3 O15379 1/20 0.43
DYRK1A Q13627 1/20 0.43
KLKB1 P03952 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27741570 0.80 EGFR (0.51) METPDE10AKLKB1KLK1
SCHEMBL28205301 0.77 L3MBTL1 (0.51) METALDH1A1MAPTATMKDM4E
SCHEMBL27022434 0.77 ALDH1A1 (0.56) METALDH1A1PDE10ANPC1RAB9A
SCHEMBL1163489 0.77 MET (0.41) METALDH1A1MAPTATMKDM4E
SCHEMBL28864698 0.77 NPC1 (0.35) METALDH1A1KDM4EHTTNPC1
SCHEMBL27997631 0.74 ALDH1A1 (0.49) METALDH1A1MAPTATMKDM4E
SCHEMBL28262231 0.74 ALDH1A1 (0.49) METALDH1A1MAPTATMKDM4E
SCHEMBL29520054 0.74 CHRNA7 (0.44) ALDH1A1
SCHEMBL28263726 0.74 PDE10A (0.46) METALDH1A1MAPTATMKDM4E
SCHEMBL27824234 0.73 MET (0.53) METALDH1A1MAPTATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102548995-B heterocyclic hydrazone compounds and their use for treating cancer and inflammation NOVARTIS AG 2015-01-28 CN disclosed
CN-102574853-B Heterocyclic oxime compounds NOVARTIS AG 2015-01-21 CN disclosed
EP-2018383-B1 TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS PFIZER PROD INC (US) 2011-11-09 EP disclosed
CN-101443331-A Triazolopyrazine derivatives useful as anti-cancer agents PFIZER PROD INC (US) 2009-05-27 CN disclosed